Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations.
The company expects sales of $3 billion to $3.1 billion, below the Street consensus of $3.3 billion.
Sage Therapeutics (NASDAQ:SAGE) stock soared after the firm announced that it had received an unsolicited takeover bid from Biogen Inc (NASDAQ:BIIB, ETR:IDP).
Biogen has proposed to acquire all of Sage’s shares that it does not already own for $7.22 per share.
Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has commenced human testing of its barium contrast product line, marking a key step toward its anticipated market launch later this year.
Shares of the company surged on the news, adding almost 18% late morning on Monday.
The Biden administration has proposed new rules governing the export of advanced AI chips and technologies to about 120 countries.
The framework, published on Monday, introduces a tiered system categorizing countries based on their relationship with the US.